Advertisement

Browse Subject Areas

?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

Plasma cell disorders

Adherence to immunomodulatory drugs in patients with multiple myeloma

Amélie Cransac, Serge Aho, Marie-Lorraine Chretien, Maurice Giroud, Denis Caillot, Mathieu Boulin

published 27 Mar 2019

Loading metrics information...

Metrics unavailable. Please check back later.

Baseline identification of clonal V(D)J sequences for DNA-based minimal residual disease detection in multiple myeloma

Even H. Rustad, Malin Hultcrantz, Venkata D. Yellapantula, Theresia Akhlaghi, Caleb Ho, Maria E. Arcila, Mikhail Roshal, Akshar Patel, Denise Chen, Sean M. Devlin, Austin Jacobsen, Ying Huang, Jeffrey E. Miller, Elli Papaemmanuil, Ola Landgren

published 22 Mar 2019

Loading metrics information...

Metrics unavailable. Please check back later.

Infectious complications and NK cell depletion following daratumumab treatment of Multiple Myeloma

Hareth Nahi, Michael Chrobok, Charlotte Gran, Johan Lund, Astrid Gruber, Gösta Gahrton, Per Ljungman, Arnika Kathleen Wagner, Evren Alici

published 13 Feb 2019

Loading metrics information...

Metrics unavailable. Please check back later.

Extracellular vesicle-associated procoagulant phospholipid and tissue factor activity in multiple myeloma

Thøger Nielsen, Søren Risom Kristensen, Henrik Gregersen, Elena Manuela Teodorescu, Gunna Christiansen, Shona Pedersen

published 14 Jan 2019

Loading metrics information...

Metrics unavailable. Please check back later.

Differentiation of multiple myeloma and metastases: Use of axial diffusion-weighted MR imaging in addition to standard MR imaging at 3T

Ga Eun Park, Won-Hee Jee, So-Yeon Lee, Jin-Kyeong Sung, Joon-Yong Jung, Robert Grimm, Yohan Son, Mun Young Paek, Chang-Kee Min, Kee-Yong Ha

published 17 Dec 2018

Loading metrics information...

Metrics unavailable. Please check back later.

Clinical outcomes of bortezomib-based therapy in myeloma

Faouzi Djebbari, Anandagopal Srinivasan, Grant Vallance, Sally Moore, Jaimal Kothari, Karthik Ramasamy

published 12 Dec 2018

Loading metrics information...

Metrics unavailable. Please check back later.

PCSeg: Color model driven probabilistic multiphase level set based tool for plasma cell segmentation in multiple myeloma

Anubha Gupta, Pramit Mallick, Ojaswa Sharma, Ritu Gupta, Rahul Duggal

published 12 Dec 2018

Loading metrics information...

Metrics unavailable. Please check back later.

Real-world treatment outcomes in multiple myeloma: Multicenter registry results from Finland 2009-2013

Kari Remes, Pekka Anttila, Raija Silvennoinen, Mervi Putkonen, Hanna Ollikainen, Venla Terävä, Marjatta Sinisalo, Kristiina Kananen, Frida Schain, Päivi Castren-Kortegangas, Tiina M. Järvinen, Marta Pisini, Felix Wahl, Tricia Dixon, Amy Leval

published 05 Dec 2018

Loading metrics information...

Metrics unavailable. Please check back later.

Regularization and grouping -omics data by GCA method: A transcriptomic case

Monika Piwowar, Kinga A. Kocemba-Pilarczyk, Piotr Piwowar

published 01 Nov 2018

Loading metrics information...

Metrics unavailable. Please check back later.

Macrophage Inhibitory Factor-1 (MIF-1) controls the plasticity of multiple myeloma tumor cells

Danielle Joseph, Jason P. Gonsky, Stacy W. Blain

published 01 Nov 2018

Loading metrics information...

Metrics unavailable. Please check back later.

Dietary intake is associated with risk of multiple myeloma and its precursor disease

Marianna Thordardottir, Ebba K. Lindqvist, Sigrun H. Lund, Rene Costello, Debra Burton, Laufey Steingrimsdottir, Neha Korde, Sham Mailankody, Gudny Eiriksdottir, Lenore J. Launer, Vilmundur Gudnason, Tamara B. Harris, Ola Landgren, Johanna E. Torfadottir, Sigurdur Y. Kristinsson

published 01 Nov 2018

Loading metrics information...

Metrics unavailable. Please check back later.

A simple approach for multi-targeted shRNA-mediated inducible knockdowns using Sleeping Beauty vectors

Severin Fink, Laurens Zugelder, Bernhard Roth, Evelyn Brandt, Sylvain Meloche, Zsuzsanna Izsvák, Ralf C. Bargou, Thorsten Stühmer

published 19 Oct 2018

Loading metrics information...

Metrics unavailable. Please check back later.

Prognostic utility of serum free light chain ratios and heavy-light chain ratios in multiple myeloma in three PETHEMA/GEM phase III clinical trials

Lucia Lopez-Anglada, Cecilia Cueto-Felgueroso, Laura Rosiñol, Albert Oriol, Ana Isabel Teruel, Ana Lopez de la Guia, Enrique Bengoechea, Luis Palomera, Felipe de Arriba, Jose Mariano Hernandez, Miquel Granell, Francisco Javier Peñalver, Ramon Garcia-Sanz, Juan Besalduch, Yolanda Gonzalez, Rafael Benigno Martinez, Miguel Teodoro Hernandez, Norma C. Gutierrez, Paloma Puerta, Antonio Valeri, Bruno Paiva, Joan Blade, Maria-Victoria Mateos, Jesus San Miguel, Juan Jose Lahuerta, Joaquin Martinez-Lopez, on behalf of the GEM (Grupo Español de MM)/PETHEMA (Programa para el Estudio de la Terapéutica en Hemopatías Malignas) Cooperative Study Group

published 07 Sep 2018

Loading metrics information...

Metrics unavailable. Please check back later.

Advertisement

Create a weekly email alert for: Plasma cell disorders

You can change these options by clicking profile then "Alerts and Notifications"